Request for Comment: National Center for Complementary and Alternative Medicine Announcement of Strategic Planning Background Papers, 54589 [E9-25307]

Download as PDF Federal Register / Vol. 74, No. 203 / Thursday, October 22, 2009 / Notices Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Lawrence E. Boerboom, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5156, MSC 7814, Bethesda, MD 20892, (301) 435– 8367, boerboom@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 14, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–25405 Filed 10–21–09; 8:45 am] Contact Person: Ross D. Shonat, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5156, MSC 7849, Bethesda, MD 20892, 301–435– 2786, shonatr@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 15, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–25471 Filed 10–21–09; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Center for Scientific Review; Notice of Closed Meetings dcolon on DSK2BSOYB1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; ARRA AREA Special Emphasis Panel 07. Date: November 17, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Beacon Hotel and Corporate Quarters, 1615 Rhode Island Avenue, NW., Washington, DC 20036. Contact Person: Rolf Menzel, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3196, MSC 7808, Bethesda, MD 20892, 301–435– 0952, menzelro@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–OD– 09–008 BRDG–SPAN and RFA–OD–09–009 Catalyst ARRA Review Panel 8. Date: November 23, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: The Fairmont Washington, DC, 2401 M Street, NW., Washington, DC 20037. 15:13 Oct 21, 2009 Jkt 220001 three background papers that will support the development of NCCAM’s third strategic plan. Comments may be provided through the NCCAM Web site at https://nccam.nih.gov. For Further Information: To request more information, visit the NCCAM Web site at https://nccam.nih.gov, call 1–888–644–6226, or e-mail <ncamsp@mail.nih.gov> Comments Due Date: Comments regarding the draft of NCCAM’s strategic plan are best assured of having their full effect if received by November 19, 2009. Dated: October 13, 2009. Jack Killen, Deputy Director, National Center for Complementary and Alternative Medicine, National Institutes of Health. [FR Doc. E9–25307 Filed 10–21–09; 8:45 am] BILLING CODE 4140–01–M National Institutes of Health National Institutes of Health VerDate Nov<24>2008 54589 Request for Comment: National Center for Complementary and Alternative Medicine Announcement of Strategic Planning Background Papers ACTION: Notice. The National Center for Complementary and Alternative Medicine (NCCAM) is developing its third strategic plan and invites the public to provide comments on three background papers which will support the development of this plan. The papers will cover three topics: Mission, priority setting, and communications and decisionmaking. They will be publicly available through the NCCAM Web site at from on or about October 19 through November 19, 2009. The public is invited to provide comments through the NCCAM Web site. Background: The National Center for Complementary and Alternative Medicine (NCCAM) was established in 1998 with the mission of exploring complementary and alternative healing practices in the context of rigorous science, training CAM researchers, and disseminating authoritative information to the public and professionals. To date, NCCAM’s efforts to rigorously study CAM, to train CAM researchers, and to communicate with the public and professionals, have been guided by NCCAM’s previous strategic plans, located on the NCCAM Web site at https://nccam.nih.gov/about/plans. The public is invited to review the background papers and provide comments from October 15 through November 15, 2009. The papers may be viewed at https://nccam.nih.gov/. Request For Comments: The public is invited to provide comments on the SUMMARY: PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0664] Request for Notification From Industry Organizations Interested in Participating in Selection Process for Nonvoting Industry Representatives on Public Advisory Committees and Request for Nominations for Nonvoting Industry Representatives on Public Advisory Committees AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is requesting that any industry organizations interested in participating in the selection of nonvoting industry representatives to serve on its public advisory committees for the Center for Food Safety and Applied Nutrition (CFSAN) notify FDA in writing. FDA is also requesting nominations for nonvoting industry representatives to serve on CFSAN’s Food Advisory Committee. A nominee may either be self-nominated or nominated by an organization to serve as a nonvoting industry representative. Nominations will be accepted for current vacancies effective with this notice. DATES: Any industry organization interested in participating in the selection of an appropriate nonvoting member to represent industry interests must send a letter stating that interest to FDA by November 23, 2009, for vacancies listed in this notice. Concurrently, nomination materials for E:\FR\FM\22OCN1.SGM 22OCN1

Agencies

[Federal Register Volume 74, Number 203 (Thursday, October 22, 2009)]
[Notices]
[Page 54589]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-25307]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Request for Comment: National Center for Complementary and 
Alternative Medicine Announcement of Strategic Planning Background 
Papers

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Center for Complementary and Alternative Medicine 
(NCCAM) is developing its third strategic plan and invites the public 
to provide comments on three background papers which will support the 
development of this plan. The papers will cover three topics: Mission, 
priority setting, and communications and decisionmaking. They will be 
publicly available through the NCCAM Web site at from on or about 
October 19 through November 19, 2009. The public is invited to provide 
comments through the NCCAM Web site.
    Background: The National Center for Complementary and Alternative 
Medicine (NCCAM) was established in 1998 with the mission of exploring 
complementary and alternative healing practices in the context of 
rigorous science, training CAM researchers, and disseminating 
authoritative information to the public and professionals.
    To date, NCCAM's efforts to rigorously study CAM, to train CAM 
researchers, and to communicate with the public and professionals, have 
been guided by NCCAM's previous strategic plans, located on the NCCAM 
Web site at https://nccam.nih.gov/about/plans.
    The public is invited to review the background papers and provide 
comments from October 15 through November 15, 2009. The papers may be 
viewed at https://nccam.nih.gov/.
    Request For Comments: The public is invited to provide comments on 
the three background papers that will support the development of 
NCCAM's third strategic plan. Comments may be provided through the 
NCCAM Web site at https://nccam.nih.gov.
    For Further Information: To request more information, visit the 
NCCAM Web site at https://nccam.nih.gov, call 1-888-644-6226, or e-mail 
<ncamsp@mail.nih.gov
    Comments Due Date: Comments regarding the draft of NCCAM's 
strategic plan are best assured of having their full effect if received 
by November 19, 2009.

    Dated: October 13, 2009.
Jack Killen,
Deputy Director, National Center for Complementary and Alternative 
Medicine, National Institutes of Health.
[FR Doc. E9-25307 Filed 10-21-09; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.